GOLIVER THERAPEUTICS
Repair the liver without graft
Repair the liver without graft
GoLiver Therapeutics is a biotechnology startup based in France, founded in 2017. The company's slogan "Repair the liver without graft" reflects its focus on developing cell-based Advanced Therapy Medicinal Products (ATMP) to address an urgent unmet medical need in transplantation. As a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), GoLiver Therapeutics is poised to become a worldwide leader in regenerative medicine, aiming to provide the first cell-based therapy product for life-threatening liver failures. In March 2021, the company received a €1.00M grant investment from the Government of France, which signifies a strong endorsement of their potential impact in the field. This investment bolsters their efforts towards pioneering solutions for liver regeneration, positioning them as a key player in the burgeoning sector of advanced cellular therapies. With this latest support, GoLiver Therapeutics is well-positioned to continue their innovative work and potentially revolutionize treatment options for liver-related ailments.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | €1.00M | 1 | Government of France | 25 Mar 2021 |
No recent news or press coverage available for GOLIVER THERAPEUTICS.
We care about your data, and we'd love to use cookies make your experience better.
